tetano
Editor, Senior Moderator
Cureus
. 2020 May 9;12(5):e8038.
doi: 10.7759/cureus.8038.
Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient
Avantika Chenna[SUP] 1 2 [/SUP], Venu Madhav Konala[SUP] 3 4 [/SUP], Vijay Gayam[SUP] 5 [/SUP], Srikanth Naramala[SUP] 6 [/SUP], Sreedhar Adapa[SUP] 7 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality worldwide. Transplant patients are particularly at a higher risk of contracting COVID-19 because of their immunosuppressed state, and they have the propensity to develop opportunistic infections. The pre-immunosuppressed state, along with other existing comorbidities, can influence the outcomes of COVID-19 in transplant patients. We describe a case of a renal transplant patient who developed COVID-19. Real-time nucleic acid testing (NAT) should be done in deceased and living donors. The most common management strategy is the modification of immunosuppression along with current experimental strategies for COVID-19.
Keywords: acute respiratory distress syndrome; coronavirus; covid-19; renal transplant
. 2020 May 9;12(5):e8038.
doi: 10.7759/cureus.8038.
Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient
Avantika Chenna[SUP] 1 2 [/SUP], Venu Madhav Konala[SUP] 3 4 [/SUP], Vijay Gayam[SUP] 5 [/SUP], Srikanth Naramala[SUP] 6 [/SUP], Sreedhar Adapa[SUP] 7 [/SUP]
Affiliations
- PMID: 32528774
- PMCID: PMC7282362
- DOI: 10.7759/cureus.8038
Abstract
Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality worldwide. Transplant patients are particularly at a higher risk of contracting COVID-19 because of their immunosuppressed state, and they have the propensity to develop opportunistic infections. The pre-immunosuppressed state, along with other existing comorbidities, can influence the outcomes of COVID-19 in transplant patients. We describe a case of a renal transplant patient who developed COVID-19. Real-time nucleic acid testing (NAT) should be done in deceased and living donors. The most common management strategy is the modification of immunosuppression along with current experimental strategies for COVID-19.
Keywords: acute respiratory distress syndrome; coronavirus; covid-19; renal transplant